서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 15 of 15

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2008-08	MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type Yoon, S. O.; Jeon, Y. K.; Paik, J. H.; Kim, W. Y.; Kim, Y. A.; Kim, J. E.; Kim, C. W. Histopathology, Vol.53 No.2, pp.205-217	DOI
2009-10	Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy Han, Hye-Suk; Kim, Jin-Soo; Park, Jin Hyun; Jeon, Yoon Kyung; Lee, Keun-Wook; Oh, Do-Youn; Kim, Jee Hyun; Park, So Yeon; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Bang, Yung-Jue Journal of Korean Medical Science, Vol.24 No.5, pp.910-917	view file DOI
2011-05	Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeon, Yoon Kyung; Park, In Ae; Han, Wonshick; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You Japanese Journal of Clinical Oncology, Vol.41 No.5, pp.593-599	DOI
2011-11	Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma Kim, Min A.; Lee, Hyuk-Joon; Yang, Han-Kwang; Bang, Yung-Jue; Kim, Woo Ho Histopathology, Vol.59 No.5, pp.822-831	DOI
2012-04	The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen Kim, Jin Won; Im, Seock-Ah; Kim, Miso; Cha, Yongjun; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Min A.; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Anticancer Research, Vol.32 No.4, pp.1547-1553
2013-06	Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome Choi, Yoon Jin; Kim, Nayoung; Paik, Jin Ho; Kim, Jung Mogg; Lee, Sang Hyub; Park, Young Soo; Hwang, Jin-Hyeok; Kim, Jin-Wook; Jeong, Sook-Hyang; Lee, Dong Ho; Jung, Hyun Chae Helicobacter, Vol.18 No.3, pp.197-205	DOI
2014-05	Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas Seo, A. N.; Yang, J. M.; Kim, H.; Jheon, S.; Kim, K.; Lee, C. T.; Jin, Y.; Yun, S.; Chung, J-H; Paik, J. H. British Journal of Cancer, Vol.110 No.11, pp.2688-2699	DOI
2014-07	Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study Satoh, Taroh; Xu, Rui-Hua; Chung, Hyun Cheol; Sun, Guo-Ping; Doi, Toshihiko; Xu, Jian-Ming; Tsuji, Akihito; Omuro, Yasushi; Li, Jin; Wang, Jin-Wan; Miwa, Hiroto; Qin, Shu-Kui; Chung, Ik-Joo; Yeh, Kun-Huei; Feng, Ji-Feng; Mukaiyama, Akihira; Kobayashi, Mikiro; Ohtsu, Atsushi; Bang, Yung-Jue Journal of Clinical Oncology, Vol.32 No.19, pp.2039-U89	DOI
2015-06	Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer Ock, Chan-Young; Lee, Keun-Wook; Kim, Jin Won; Kim, Jin-Soo; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue; Oh, Do-Youn Clinical Cancer Research, Vol.21 No.11, pp.2520-2529	DOI
2015-07	HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer Van Cutsem, Eric; Bang, Yung-Jue; Feng-Yi, Feng; Xu, Jian M.; Lee, Keun-Wook; Jiao, Shun-Chang; Chong, Jorge Leon; Lopez-Sanchez, Roberto I.; Price, Timothy; Gladkov, Oleg; Stoss, Oliver; Hill, Julie; Ng, Vivian; Lehle, Michaela; Thomas, Marlene; Kiermaier, Astrid; Rueschoff, Josef Gastric Cancer, Vol.18 No.3, pp.476-484	DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2017-01	HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-O13/LOGiC Trial of Lapatinib Press, Michael F.; Ellis, Catherine E.; Gagnon, Robert C.; Grob, Tobias J.; Buyse, Marc; Villalobos, Ivonne; Liang, Zhiyong; Wu, Shafei; Bang, Yung-Jue; Qin, Shu-Kui; Chung, Hyun Cheol; Xu, Jianming; Park, Joon Oh; Jeziorski, Krzysztof; Afenjar, Karen; Ma, Yanling; Estrada, Monica C.; Robinson, Douglas M.; Scherer, Stefan J.; Sauter, Guido; Hecht, J. Randolph; Slamon, Dennis J. Molecular Cancer Therapeutics, Vol.16 No.1, pp.228-238	DOI
2017-04	MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics Kwon, Dohee; Koh, Jaemoon; Kim, Sehui; Go, Heounjeong; Kim, Young A; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Jeon, Yoon Kyung; Chung, Doo Hyun Lung Cancer, Vol.106, pp.131-137	DOI
2017-05	Molecular Testing of Lung Cancers Shim, Hyo Sup; Choi, Yoon-La; Kim, Lucia; Chang, Sunhee; Kim, Wan-Seop; Roh, Mee Sook; Kim, Tae-Jung; Ha, Seung Yeon; Chung, Jin-Haeng; Jang, Se Jin; Lee, Geon Kook Journal of Pathology and Translational Medicine, Vol.51 No.3, pp.242-254	DOI
2020-01	HER2-targeted therapies - a role beyond breast cancer Oh, Do-Youn; Bang, Yung-Jue Nature Reviews Clinical Oncology, Vol.17 No.1, pp.33-48	DOI

1